Solid Biosciences (SLDB) executive compensation, 2026 proxy

Alexander Cumbo, President and Chief Executive Officer, was paid $5.2M in 2025, up 7% from $4.9M the year before.

Filed
April 23, 2026
Annual meeting
June 10, 2026
Pay year
2025
Named executives
3
CEO total pay
$5.2M+7% vs prior year
CEO pay in equity
79%$4.1M in awards
CEO 2025 Salary
$650,988Base salary
CEO 2025 Bonus
$449,182Discretionary cash bonus
CEO 2026 Target Bonus
60%Percentage of base salary

How Cumbo was paid

$5.2M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary12%Bonus9%Stock awards44%Option awards34%All other compensation0%

Named executive officers

ExecutiveTotal
Alexander CumboPresident and Chief Executive Officer$5,223,442
Gabriel Brooks, M.D.Chief Medical Officer$2,328,156
David Tyronne HowtonChief Operating Officer and Secretary$2,588,827

What changed and why

  • $5.2MAlexander Cumbo received total compensation of $5,223,442 in 2025, representing an increase from $4,869,909 in 2024.
  • 100%The board awarded discretionary cash bonuses to executives for 2025 performance, equating to 100% of their target bonuses.
  • Named executive officers received both RSU and stock option grants during the 2025 fiscal year.
  • For 2026, base salaries were increased for the chief executive officer and other named executive officers.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.